COVID-19 to stay with us for generations, says IIPH Director Professor G V S Murthy

Available data from different states suggests that June-end may see a significant downward spiral in COVID-19 cases in south and west India, he said.

PTI
May 27, 2021 / 01:07 PM IST

The active cases have increased to 37,10,525 comprising 15.65 per cent of the total infections. The national COVID-19 recovery rate has improved to 83.26 per cent, the data updated at 8 am showed.

Like the flu, COVID-19 is here to stay for generations, according to the Director of the Indian Institute of Public Health-Hyderabad, Prof. G V S Murthy.

Available data from different states suggests that June-end may see a significant downward spiral in COVID-19 cases in south and west India, he said.

"In north and east India, it may be mid-July for a significant decrease in the cases", Prof. Murthy told P T I on Thursday.

Allowing political, social and religious gatherings too early in the life of the pandemic is one of the prime reasons for the rapid fueling of cases in the second wave, according to him.

Despite signals emerging from February that we could see an upswing of cases, prompt public health response was lacking, he said, adding this is because public health professionals have not been engaged in the response.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"In all countries where the COVID-19 response was quick and need-based, there was authority and responsibility vested in the public health leadership. Unfortunately, the same was not seen in India where it was more of a non-public health or political response," Prof. Murthy said.

He said COVID-19 is here to stay with us for a long time.

An infectious agent once introduced into the community, continues to simmer and lead to localised outbreaks.

"Flu has been with us for generations now and the same will be the course of COVID-19," he said.

He is of the view that outbreaks will occur whenever a large number of people susceptible to the infection are available.

"We know that post the COVID-19 infection, immunity is only for a short duration of 3-6 months, after which the same person is vulnerable to getting reinfected. The reinfection will depend on the viral load to which the susceptible person is exposed to. We have seen some Chief Ministers and national leaders also getting infected a second time. So nobody is permanently immune," Prof. Murthy said.

According to him, it will take five to six months for the next COVID-19 wave to occur as, by then, the population immunity will once again wane off.

"So November could again be a worrying time".

In pandemics, it is the older and more infirm people who succumb first, but with each succeeding wave, more of the middle-aged and younger people, including children, get infected.

This is the danger of the next wave, he said.

"If the country can vaccinate more than 80 per cent of those above 30 years of age by November, we will be able to mount an effective challenge to the spread of COVID," Prof. Murthy said.

At the same time, efforts should be made to field-test available vaccines in children so that if possible, the vaccine can be added to the "Universal Programme of Immunisation" in the country.

Prof. Murthy underlined that there needs to be a continued ban on large gatherings till February 2022 if we have to reduce the risk.

Schools and offices can be opened up with adequate precautions.

"If the country does not create a public health cadre with adequate decision-making authority being vested in them, from the district-level onwards, we will always be playing a catch-up game rather than planning proactively with adequate projections and data," he opined.
PTI
TAGS: #coronavirus #Covid-19 #Current Affairs #IIPH director #India #Professor G V S Murthy
first published: May 27, 2021 01:07 pm